Synergistic potential of sipuleucel-T in enhancing immunotherapy for metastatic castration-resistant prostate cancer
Clinical trials of immunotherapy in metastatic castration-resistant prostate cancer (mCRPC) have largely been unsuccessful despite promising preclinical studies and proven efficacy in other solid tumors. These disappointing clinical outcomes have been attributed to an immunosuppressive tumor microen...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2025-12-01
|
| סדרה: | Journal for ImmunoTherapy of Cancer |
| גישה מקוונת: | https://jitc.bmj.com/content/13/12/e012690.full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|